| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
38,951,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile IsoPlexis is a life sciences company building solutions to accelerate the development of curative medicines and personalized therapeutics. Co.'s single cell proteomics platform, which includes instruments, chip consumables and software, provides an end-to-end solution to reveal a more complete view of protein function at an individual cellular level. Co.'s initial focus has been on developing applications of its platform for cancer immunology and cell and gene therapy. Co.'s platform is an end-to-end solution comprised of its proprietary IsoLight and IsoSpark instruments, IsoCode and CodePlex chip consumables, and IsoSpeak software.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
95,253 |
| Total Buy Value |
$0 |
$0 |
$0 |
$186,762 |
| Total People Bought |
0 |
0 |
0 |
4 |
| Total Buy Transactions |
0 |
0 |
0 |
5 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Shamir Nachum |
Director |
– • – |
2023-03-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(50,253) |
0 |
|
- |
|
| Zhou Jing |
Chief Scientific Officer |
• – – |
2023-03-21 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,200) |
0 |
|
- |
|
| Mackay Sean |
Chief Executive Officer |
• • – |
2023-03-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(914,366) |
0 |
|
- |
|
| Conley John G. |
Director |
– • – |
2023-03-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(100,752) |
0 |
|
- |
|
| Khakhar Rajesh T. |
VP Finance |
• – – |
2023-03-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(14,583) |
0 |
|
- |
|
| Rew Richard W. Ii |
SVP, GC and Secretary |
• – – |
2023-03-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(20,000) |
0 |
|
- |
|
| Strahley John |
Chief Financial Officer |
• – – |
2023-03-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(65,000) |
0 |
|
- |
|
| Ho Gregory P. |
Director |
– • – |
2023-03-21 |
4 |
D |
$0.00 |
$0 |
I/I |
(6,064,661) |
0 |
|
- |
|
| Heath James R |
Director |
– • – |
2023-03-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(201,888) |
0 |
|
- |
|
| Heath James R |
Director |
– • – |
2023-03-10 |
4 |
OE |
$0.13 |
$71,825 |
D/D |
201,888 |
201,888 |
|
- |
|
| Conley John G. |
Director |
– • – |
2023-01-30 |
4 |
OE |
$0.73 |
$30,871 |
D/D |
36,000 |
100,752 |
|
- |
|
| Shamir Nachum |
Director |
– • – |
2022-08-31 |
4 |
B |
$1.94 |
$77,728 |
D/D |
40,000 |
50,253 |
2.39 |
- |
|
| Shamir Nachum |
Director |
– • – |
2022-08-30 |
4 |
B |
$1.89 |
$19,384 |
D/D |
10,253 |
10,253 |
2.39 |
- |
|
| Mackay Sean |
Chief Executive Officer |
• • – |
2022-08-25 |
4 |
B |
$1.99 |
$29,850 |
D/D |
15,000 |
914,366 |
2.81 |
- |
|
| Strahley John |
Chief Financial Officer |
• – – |
2022-08-25 |
4 |
B |
$2.00 |
$20,000 |
D/D |
10,000 |
65,000 |
2.74 |
- |
|
| Rew Richard W. Ii |
SVP, GC and Secretary |
• – – |
2022-08-25 |
4 |
B |
$1.99 |
$39,800 |
D/D |
20,000 |
20,000 |
2.74 |
- |
|
| Mackay Sean |
Chief Executive Officer |
• • – |
2022-08-19 |
4 |
OE |
$0.28 |
$27,926 |
D/D |
100,166 |
899,366 |
|
- |
|
| Strahley John |
Chief Financial Officer |
• – – |
2022-08-17 |
4 |
OE |
$1.03 |
$15,413 |
D/D |
15,000 |
55,000 |
|
- |
|
| Strahley John |
Chief Financial Officer |
• – – |
2022-06-03 |
4 |
OE |
$1.03 |
$15,413 |
D/D |
15,000 |
40,000 |
|
- |
|
| Strahley John |
Chief Financial Officer |
• – – |
2022-04-22 |
4 |
OE |
$1.03 |
$12,844 |
D/D |
12,500 |
25,000 |
|
- |
|
| Siesel Peter |
Chief Commercial Officer |
• – – |
2022-04-06 |
4 |
A |
$0.00 |
$0 |
D/D |
140,000 |
140,000 |
|
- |
|
| Strahley John |
Chief Financial Officer |
• – – |
2021-12-10 |
4 |
OE |
$1.03 |
$12,844 |
D/D |
12,500 |
12,500 |
|
- |
|
| Khakhar Rajesh T. |
VP, Finance |
• – – |
2021-12-06 |
4 |
A |
$0.00 |
$0 |
D/D |
14,583 |
14,583 |
|
- |
|
| Edelman Joseph |
10% Owner |
– – • |
2021-10-12 |
4 |
B |
$15.00 |
$12,750,000 |
I/I |
850,000 |
3,554,587 |
1.5 |
- |
|
| Edelman Joseph |
10% Owner |
– – • |
2021-10-12 |
4 |
A |
$0.00 |
$0 |
I/I |
3,245,498 |
204,949 |
|
- |
|
31 Records found
|
|
Page 1 of 2 |
|
|
